4//SEC Filing
Wilfong Diane E. 4
Accession 0001127602-23-003825
CIK 0000882095other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:47 PM ET
Size
8.2 KB
Accession
0001127602-23-003825
Insider Transaction Report
Form 4
Wilfong Diane E
Interim Corp Controller & CAO
Transactions
- Exercise/Conversion
Common Stock
2023-02-06+1,864→ 32,575 total - Tax Payment
Common Stock
2023-02-06$86.36/sh−565$48,793→ 32,010 total - Exercise/Conversion
Restricted Stock Unit
2023-02-06−1,864→ 11,060 total→ Common Stock (1,864 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001374988
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 5:47 PM ET
- Size
- 8.2 KB